EXICURE, INC. Current Portion of Long-Term Debt
EXICURE, INC. (XCUR) had Current Portion of Long-Term Debt of $1.00 million as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LongTermDebtCurrent · last filed 2024-08-13
- 2024-06-30: Long-term Debt, Current Maturities $1.00M.
- 2023-12-31: Long-term Debt, Current Maturities $0.00.
- 2022-12-31: Long-term Debt, Current Maturities $0.00.
- 2022-09-30: Long-term Debt, Current Maturities $0.00.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2024-06-30 | $1.00M 10-Q · filed 2024-08-13 |
| 2023-12-31 | $0.00 10-Q · filed 2024-08-13 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-27 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-12-31 | $6.87M 10-K · filed 2023-03-27 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-19 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-12 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 |
| 2019-12-31 | $4.96M 10-K · filed 2021-03-11 |
| 2019-09-30 | $4.91M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.86M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $4.81M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-10 |
| 2018-09-30 | $4.93M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.57M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $776.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $0.00 10-Q · filed 2018-11-06 |
| 2017-09-30 | $2.55M 10-Q · filed 2017-11-14 |
| 2016-12-31 | $1.21M 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |